Medifast, Inc. (LON:0K05)
| Market Cap | 81.73M -40.9% |
| Revenue (ttm) | 319.67M -36.3% |
| Net Income | 184.50K -96.6% |
| EPS | 0.01 -97.0% |
| Shares Out | n/a |
| PE Ratio | 442.97 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 69 |
| Average Volume | 7,276 |
| Open | 11.10 |
| Previous Close | 11.03 |
| Day's Range | 10.70 - 11.10 |
| 52-Week Range | 10.05 - 16.55 |
| Beta | 0.54 |
| RSI | 44.46 |
| Earnings Date | Feb 17, 2026 |
About Medifast
Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and sou... [Read more]
Financial Performance
In 2024, Medifast's revenue was $602.46 million, a decrease of -43.80% compared to the previous year's $1.07 billion. Earnings were $2.09 million, a decrease of -97.90%.
Financial numbers in USD Financial StatementsNews
People Magazine Spotlights Tiffany Howard's Metabolic Health Journey with OPTAVIA®
BALTIMORE--(BUSINESS WIRE)--Medifast® (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system OPTAVIA, celebrates the inspiring health transformation o...
OPTAVIA® Premieres Second Docuseries Episode “Health by Design: Spain” Exploring Metabolic Health and Longevity
BALTIMORE--(BUSINESS WIRE)--Medifast® (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system OPTAVIA, premiered its newest docuseries episode, “Health...
Medifast Shifts to Metabolic Health: A Durable Growth Path?
MED is pivoting to metabolic health, using clinical data and new products to address root causes beyond GLP-1 weight loss.
Medifast Announces Planned Leadership Transition
BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) today announced a planned leadership transition designed to provide continuity and stability as the company continues its evolution toward metabo...
Medifast New Product Line Planned: Can Innovation Reignite Demand?
MED plans a new product line rooted in metabolic synchronization science, upgrading its core offerings as it shifts beyond weight loss.
Medifast's Third-Quarter Revenue Fell 36%: Is Stabilization Near?
MED witnesses revenue plunge as its coach base shrank, but restructuring and productivity initiatives aim to stabilize results by late 2025.
OPTAVIA Survey Reveals 80% of Americans Lack Understanding of Metabolic Health Despite Its Major Impact to Overall Health and Wellbeing
BALTIMORE--(BUSINESS WIRE)--OPTAVIA, the science-backed, coach-guided lifestyle system, announced a new report “Metabolic Health in America: Awareness, Attitudes and Action.” The report includes findi...
Medifast Scientific & Clinical Affairs Team Showcases New Research in Metabolic Health at ObesityWeek Conference
BALTIMORE--(BUSINESS WIRE)--Medifast, the health and wellness company known for its science-backed, coach-guided lifestyle system, continues to lead the charge in addressing the growing health crisis ...
Medifast's Q3 Loss Wider Than Expected, Sales Decline 36% Y/Y
MED's third-quarter results reflect pressure from fewer active OPTAVIA Coaches, but it is steering toward metabolic health for growth.
Medifast Inc (MED) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...
Medifast Inc (MED) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic Innovations
Q3 2025 Medifast Inc Earnings Call Transcript
Q3 2025 Medifast Inc Earnings Call Transcript
Medifast outlines Q4 2025 revenue guidance of $65M–$80M amid strategic shift to metabolic health solutions
Medifast, Inc. (MED) Q3 2025 Earnings Call Transcript
Medifast, Inc. (MED) Q3 2025 Earnings Call November 3, 2025 4:30 PM ESTCompany ParticipantsSteven Zenker - Vice President of Investor RelationsDaniel Chard...
Medifast, Inc. 2025 Q3 - Results - Earnings Call Presentation
Medifast Inc Q3 2025 Earnings: EPS of -$0.21 Beats Estimate, Revenue of $89. ...
Medifast Inc Q3 2025 Earnings: EPS of -$0.21 Beats Estimate, Revenue of $89.4M Surpasses Expectations
Medifast (MED) Projects Q4 Revenue Between $65M and $80M
Medifast (MED) Projects Q4 Revenue Between $65M and $80M
Medifast (MED) Reports Q3 Revenue Slightly Below Expectations
Medifast (MED) Reports Q3 Revenue Slightly Below Expectations
Medifast Announces Third Quarter 2025 Financial Results
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today reported results for the third quarter ended Septem...
Medifast (MED) Q3 Earnings Preview: Analysts Expect a Decline
Medifast (MED) Q3 Earnings Preview: Analysts Expect a Decline
Medifast Q3 2025 Earnings Preview
Get the latest Medifast (MED) Q3 earnings preview, analyst projections, and historical beat rates.
Earnings Outlook For Medifast
Medifast (NYSE: MED) is gearing up to announce its quarterly earnings on Monday, 2025-11-03. Here's a quick overview of what investors should know before the release. Analysts are estimating that Med...
Medifast Announces Strategic Shift to Metabolic Health with the Introduction of Metabolic Synchronization™
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its science-backed, coach-guided lifestyle system, today announced a strategic transformation, unveiling a n...
Medifast to Announce Financial Results for the Third Quarter Ended September 30, 2025
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the 40+ year old health and wellness company known for its science-backed, coach-guided lifestyle system, will announce financial results for the quar...
Evidence Links 5 & 1 Plan® to Improved Metabolic Health Outcomes
BALTIMORE--(BUSINESS WIRE)--With more than 90% of U.S. adults classified as metabolically unhealthy1, the silent crisis of metabolic dysfunction continues to escalate. This condition can be linked to ...